1. Home
  2. AROW vs KMDA Comparison

AROW vs KMDA Comparison

Compare AROW & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AROW
  • KMDA
  • Stock Information
  • Founded
  • AROW 1851
  • KMDA 1990
  • Country
  • AROW United States
  • KMDA Israel
  • Employees
  • AROW N/A
  • KMDA N/A
  • Industry
  • AROW Major Banks
  • KMDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AROW Finance
  • KMDA Health Care
  • Exchange
  • AROW Nasdaq
  • KMDA Nasdaq
  • Market Cap
  • AROW 403.4M
  • KMDA 349.1M
  • IPO Year
  • AROW N/A
  • KMDA N/A
  • Fundamental
  • Price
  • AROW $24.61
  • KMDA $6.47
  • Analyst Decision
  • AROW Hold
  • KMDA Strong Buy
  • Analyst Count
  • AROW 1
  • KMDA 3
  • Target Price
  • AROW $30.00
  • KMDA $14.67
  • AVG Volume (30 Days)
  • AROW 45.7K
  • KMDA 106.2K
  • Earning Date
  • AROW 04-29-2025
  • KMDA 05-07-2025
  • Dividend Yield
  • AROW 4.54%
  • KMDA 3.10%
  • EPS Growth
  • AROW 0.27
  • KMDA 66.67
  • EPS
  • AROW 1.77
  • KMDA 0.25
  • Revenue
  • AROW $134,626,000.00
  • KMDA $160,953,000.00
  • Revenue This Year
  • AROW $23.82
  • KMDA $14.01
  • Revenue Next Year
  • AROW $7.25
  • KMDA $9.24
  • P/E Ratio
  • AROW $13.94
  • KMDA $25.58
  • Revenue Growth
  • AROW 3.11
  • KMDA 12.93
  • 52 Week Low
  • AROW $22.08
  • KMDA $4.74
  • 52 Week High
  • AROW $34.63
  • KMDA $9.15
  • Technical
  • Relative Strength Index (RSI)
  • AROW 45.97
  • KMDA 49.43
  • Support Level
  • AROW $23.34
  • KMDA $6.36
  • Resistance Level
  • AROW $24.53
  • KMDA $6.57
  • Average True Range (ATR)
  • AROW 1.36
  • KMDA 0.28
  • MACD
  • AROW -0.03
  • KMDA 0.06
  • Stochastic Oscillator
  • AROW 51.22
  • KMDA 76.23

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: